NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>NHMRC</strong> GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA<br />
Chapter 1 – Recommendations and Evidence statements<br />
Recommendation<br />
Recommendation 7<br />
Assess risk of progression<br />
of glaucomatous damage<br />
Good Practice Points<br />
• Calculate the rate of<br />
visual field loss regularly<br />
(for example review<br />
every four months) for<br />
the first two years, and<br />
then less frequently<br />
(for example every six<br />
months) thereafter if<br />
stable. This will depend<br />
on the health care setting<br />
and the individual patient’s<br />
risk of progression.<br />
• Reduce IOP by 20-50% in<br />
patients with glaucomatous<br />
optic neuropathy depending<br />
on the level of risk to<br />
preserve visual field and<br />
to reduce progression.<br />
• Reduce IOP more<br />
aggressively in those<br />
patients with greater risk<br />
factors for progression.<br />
• Patients diagnosed late,<br />
with more advanced<br />
glaucoma damage,<br />
suffer higher rates of<br />
progression of visual loss.<br />
More aggressive IOP<br />
reduction is required.<br />
Evidence Statements<br />
No Evidence Statements for Recommendation 7. 2<br />
Evidence<br />
Statement<br />
Grade<br />
2 This recommendation was developed using expert opinion of the Working Committee<br />
National Health and Medical Research Council 15